BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29490870)

  • 1. Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients.
    Bommiasamy AK; Connelly C; Moren A; Dodgion C; Bestall K; Cline A; Martindale RG; Schreiber MA; Kiraly LN
    Am J Surg; 2018 May; 215(5):825-830. PubMed ID: 29490870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants.
    Johnston BC; Lytvyn L; Lo CK; Allen SJ; Wang D; Szajewska H; Miller M; Ehrhardt S; Sampalis J; Duman DG; Pozzoni P; Colli A; Lönnermark E; Selinger CP; Wong S; Plummer S; Hickson M; Pancheva R; Hirsch S; Klarin B; Goldenberg JZ; Wang L; Mbuagbaw L; Foster G; Maw A; Sadeghirad B; Thabane L; Mertz D
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):771-781. PubMed ID: 29695312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection.
    Abbett SK; Yokoe DS; Lipsitz SR; Bader AM; Berry WR; Tamplin EM; Gawande AA
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1062-9. PubMed ID: 19751156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
    Trick WE; Sokalski SJ; Johnson S; Bunnell KL; Levato J; Ray MJ; Weinstein RA
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):765-770. PubMed ID: 29695310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
    Marufu O; Desai N; Aldred D; Brown T; Eltringham I
    J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection incidence: impact of audit and feedback programme to improve room cleaning.
    Smith A; Taggart LR; Lebovic G; Zeynalova N; Khan A; Muller MP
    J Hosp Infect; 2016 Feb; 92(2):161-6. PubMed ID: 26679727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.
    Carvour ML; Wilder SL; Ryan KL; Walraven C; Qeadan F; Brett M; Page K
    Am J Infect Control; 2019 Jan; 47(1):2-8. PubMed ID: 30205907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority.
    Roncarati G; Dallolio L; Leoni E; Panico M; Zanni A; Farruggia P
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28075419
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Dudzicz S; Kujawa-Szewieczek A; Kwiecień K; Więcek A; Adamczak M
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30355985
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
    Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
    Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.